Jared Bearss

700 total citations
11 papers, 286 citations indexed

About

Jared Bearss is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Jared Bearss has authored 11 papers receiving a total of 286 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Immunology. Recurrent topics in Jared Bearss's work include Histone Deacetylase Inhibitors Research (3 papers), Epigenetics and DNA Methylation (3 papers) and Phagocytosis and Immune Regulation (2 papers). Jared Bearss is often cited by papers focused on Histone Deacetylase Inhibitors Research (3 papers), Epigenetics and DNA Methylation (3 papers) and Phagocytosis and Immune Regulation (2 papers). Jared Bearss collaborates with scholars based in United States. Jared Bearss's co-authors include Sunil Sharma, Venkataswamy Sorna, Emily R. Theisen, Mary C. Beckerle, Laura Hoffman, Stephen L. Lessnick, Savita Sankar, Hariprasad Vankayalapati, David J. Bearss and Anupam Verma and has published in prestigious journals such as Blood, Cancer Research and Clinical Cancer Research.

In The Last Decade

Jared Bearss

11 papers receiving 285 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jared Bearss United States 6 164 66 63 60 34 11 286
Samuel H. Myers Italy 9 144 0.9× 22 0.3× 114 1.8× 99 1.6× 75 2.2× 23 369
Jill Piens United States 4 296 1.8× 60 0.9× 32 0.5× 214 3.6× 36 1.1× 7 395
Patrizia Maddalena Italy 7 151 0.9× 26 0.4× 49 0.8× 102 1.7× 16 0.5× 14 289
Giuliana Pavone Italy 7 131 0.8× 58 0.9× 18 0.3× 105 1.8× 22 0.6× 18 282
Venkataswamy Sorna United States 5 285 1.7× 69 1.0× 13 0.2× 45 0.8× 43 1.3× 6 358
Bharani Dharan United States 6 152 0.9× 120 1.8× 24 0.4× 144 2.4× 19 0.6× 10 324
Chia C. Portera United States 10 195 1.2× 27 0.4× 60 1.0× 234 3.9× 12 0.4× 19 385
Rachael Brake United States 10 166 1.0× 87 1.3× 22 0.3× 82 1.4× 25 0.7× 26 269
Abeba Zewdu United States 8 228 1.4× 61 0.9× 23 0.4× 53 0.9× 8 0.2× 10 311
Tracy Lou United States 3 209 1.3× 57 0.9× 46 0.7× 90 1.5× 32 0.9× 3 334

Countries citing papers authored by Jared Bearss

Since Specialization
Citations

This map shows the geographic impact of Jared Bearss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jared Bearss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jared Bearss more than expected).

Fields of papers citing papers by Jared Bearss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jared Bearss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jared Bearss. The network helps show where Jared Bearss may publish in the future.

Co-authorship network of co-authors of Jared Bearss

This figure shows the co-authorship network connecting the top 25 collaborators of Jared Bearss. A scholar is included among the top collaborators of Jared Bearss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jared Bearss. Jared Bearss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Bearss, Jared, et al.. (2023). Modulation of NLRP3 Inflammasome in Monocytes By HT-6184 in a Single-Cell Proteomic Study. Blood. 142(Supplement 1). 1170–1170. 1 indexed citations
2.
Chen, Ting, Venkataswamy Sorna, Jared Bearss, et al.. (2017). Fragment-based design, synthesis, biological evaluation, and SAR of 1H-benzo[d]imidazol-2-yl)-1H-indazol derivatives as potent PDK1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 27(24). 5473–5480. 13 indexed citations
3.
Soldi, Raffaella, Stephen Horrigan, Janak Padia, et al.. (2015). Design, Synthesis, and Biological Evaluation of a Series of Anthracene-9,10-dione Dioxime β-Catenin Pathway Inhibitors. Journal of Medicinal Chemistry. 58(15). 5854–5862. 20 indexed citations
4.
Sankar, Savita, Emily R. Theisen, Jared Bearss, et al.. (2014). Reversible LSD1 Inhibition Interferes with Global EWS/ETS Transcriptional Activity and Impedes Ewing Sarcoma Tumor Growth. Clinical Cancer Research. 20(17). 4584–4597. 125 indexed citations
5.
6.
Bearss, Jared, et al.. (2013). Abstract 5543: Inhibition of the tyrosine kinase receptor Axl blocks cell invasion and promotes apoptosis in pancreatic cancer cells.. Cancer Research. 73(8_Supplement). 5543–5543. 1 indexed citations
7.
Vollmer, David, Jared Bearss, David J. Bearss, et al.. (2013). Discovery of Novel Putative Inhibitors of UDP-GlcNAc 2-Epimerase as Potent Antibacterial Agents. ACS Medicinal Chemistry Letters. 4(12). 1142–1147. 9 indexed citations
8.
Theisen, Emily R., Jared Bearss, Venkataswamy Sorna, Jeremy J. Bearss, & Sunil Sharma. (2013). Abstract 3: Targeted inhibition of LSD1 in castration-resistant prostate cancer.. Cancer Research. 73(8_Supplement). 3–3. 3 indexed citations
9.
Warner, Steven L., Mark Wade, Jared Bearss, et al.. (2011). Design, Synthesis, and Biological Evaluation of a Series of Novel AXL Kinase Inhibitors. ACS Medicinal Chemistry Letters. 2(12). 907–912. 75 indexed citations
10.
Bearss, Jared, et al.. (2009). Abstract C206: In vivo activity of SGI-1252, a potent, small-molecule dual inhibitor of JAK2 and ALK2. Molecular Cancer Therapeutics. 8(12_Supplement). C206–C206. 1 indexed citations
11.
Ahmed, Kausar Begam Riaz, Roberto Nussenzveig, Josef T. Prchal, et al.. (2008). Preclinical Characterization of the JAK-2 Inhibitor, SGI-1252. Blood. 112(11). 2629–2629. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026